
ITM Symposium on Actinium-225 Targeted Radionuclide Therapy …
The symposium titled, “Actinium-225 Targeted Radionuclide Therapy – Current Perspective and Future Outlooks” will take place on June 25, from 11:30 am to 12:55 pm CET. Participants can attend in person or join via live stream, which will be available on …
ITM and Ariceum Therapeutics Enter Into Supply Agreement for ...
2025年1月13日 · Ac-225 is a rare medical radioisotope used in RPTs for the treatment of various cancer indications. It emits high-energy alpha particles with a short penetration range in tissue, enabling precise targeting of tumor cells. This unique quality has made Ac-225 an increasingly sought-after resource in the field, with growing demand.
Potential of Actinium-225 in Targeted Alpha Therapy | Actineer
Actineer, the joint venture between ITM and CNL, is addressing the growing and urgent global demand for Actinium-225—a rare medical radioisotope that enables the development of innovative therapies for hard-to-treat tumors.
Control System INTELLIGENT TOUCH MANAGER - Daikin …
Memperkenalkan Intelligent Touch Manager Daikin, pengontrol sistem VRV dengan serangkaian fungsi manajemen sistem sederhana dan bermanfaat yang memberi Anda kendali penuh atas seluruh jaringan AC Anda dari antarmuka layar sentuh yang …
ITM-24D / ITM-22 for Prostate Cancer - ITM Radiopharma
ITM-22 (225 Ac-PSMA- TTM*) is an innovative agent for Targeted Radionuclide Therapy in patients with metastatic castration-resistant prostate cancer (mCRPC) who express Prostate-specific membrane antigen (PSMA).
ITM和CNL宣布启动Actineer全球生产Actinium-225的新合资企业
2023年10月18日 · 根据协议条款,Actineer将推进 225 Ac生产和加工技术,建立短期生产能力以大幅增加国际供应,同时长期致力于建设新的Actinium生产设施(APF),该设施将具有专门的大规模基础设施以大规模生产 225 Ac。
Ariceum Therapeutics and ITM Enter Supply Agreement for …
2025年1月13日 · Actineer™ Inc. is a joint venture company between Canadian Nuclear Laboratories (CNL) and ITM Isotope Technologies Munich SE (ITM) dedicated to advancing Ac-225 technologies, quickly securing supply, and producing industrial-scale quantities of this valuable, rare medical radioisotope for the treatment of cancer. Founded in October 2023 ...
Actineer Advances <br>Ac-225 Production | Actineer
2024年10月17日 · Actineer™ Inc. is a joint venture company between Canadian Nuclear Laboratories (CNL) and ITM Isotope Technologies Munich SE (ITM) dedicated to advancing Ac-225 technologies, quickly securing supply, and producing industrial-scale quantities of this valuable, rare medical radioisotope for the treatment of cancer. Founded in October 2023 ...
Best University in Gwalior, M.P. | ITM University
ITM University, Madhya Pradesh [ITMU] is the Best University in Madhya Pradesh and North India that offers various Undergraduate and Post graduate Courses like B.Tech, BCA, BBA, B.Com, MBA, M.Tech, B.Com, M.Com,and MCA at an affordable fees in ITM. Apply Now at India's Best Private University in Madhya Pradeh, ITM which provides top placements.
ITM and Ariceum Sign Agreement to Supply Actinium-225 for …
2025年1月14日 · ITM Isotope Technologies Munich SE and Ariceum Therapeutics have entered into a supply agreement for non-carrier-added (n.c.a.) Actinium-225 to support Ariceum’s cancer therapy pipeline. Actineer, ITM’s joint venture, will produce and supply Ac-225, advancing the development of novel radiopharmaceutical treatments for aggressive cancers.
- 某些结果已被删除